Cargando…
Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system
BACKGROUND: Mice with peroxisome deficiency in neural cells (Nestin-Pex5(−/−)) develop a neurodegenerative phenotype leading to motor and cognitive disabilities and early death. Major pathologies at the end stage of disease include severe demyelination, axonal degeneration and neuroinflammation. We...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419640/ https://www.ncbi.nlm.nih.gov/pubmed/22458306 http://dx.doi.org/10.1186/1742-2094-9-61 |
_version_ | 1782240748797689856 |
---|---|
author | Bottelbergs, Astrid Verheijden, Simon Van Veldhoven, Paul P Just, Wilhelm Devos, Rita Baes, Myriam |
author_facet | Bottelbergs, Astrid Verheijden, Simon Van Veldhoven, Paul P Just, Wilhelm Devos, Rita Baes, Myriam |
author_sort | Bottelbergs, Astrid |
collection | PubMed |
description | BACKGROUND: Mice with peroxisome deficiency in neural cells (Nestin-Pex5(−/−)) develop a neurodegenerative phenotype leading to motor and cognitive disabilities and early death. Major pathologies at the end stage of disease include severe demyelination, axonal degeneration and neuroinflammation. We now investigated the onset and progression of these pathological processes, and their potential interrelationship. In addition, the putative role of oxidative stress, the impact of plasmalogen depletion on the neurodegenerative phenotype, and the consequences of peroxisome elimination in the postnatal period were studied. METHODS: Immunohistochemistry in association with gene expression analysis was performed on Nestin-Pex5(−/−) mice to document demyelination, axonal damage and neuroinflammation. Also Gnpat(−/−) mice, with selective plasmalogen deficiency and CMV-Tx-Pex5(−/−) mice, with tamoxifen induced generalized loss of peroxisomes were analysed. RESULTS: Activation of the innate immune system is a very early event in the pathological process in Nestin-Pex5(−/−) mice which evolves in chronic neuroinflammation. The complement factor C1q, one of the earliest up regulated transcripts, was expressed on neurons and oligodendrocytes but not on microglia. Transcripts of other pro- and anti-inflammatory genes and markers of phagocytotic activity were already significantly induced before detecting pathologies with immunofluorescent staining. Demyelination, macrophage activity and axonal loss co-occurred throughout the brain. As in patients with mild peroxisome biogenesis disorders who develop regressive changes, demyelination in cerebellum and brain stem preceded major myelin loss in corpus callosum of both Nestin-Pex5(−/−) and CMV-Tx-Pex5(−/−) mice. These lesions were not accompanied by generalized oxidative stress throughout the brain. Although Gnpat(−/−) mice displayed dysmyelination and Purkinje cell axon damage in cerebellum, confirming previous observations, no signs of inflammation or demyelination aggravating with age were observed. CONCLUSIONS: Peroxisome inactivity triggers a fast neuroinflammatory reaction, which is not solely due to the depletion of plasmalogens. In association with myelin abnormalities this causes axon damage and loss. |
format | Online Article Text |
id | pubmed-3419640 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34196402012-08-16 Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system Bottelbergs, Astrid Verheijden, Simon Van Veldhoven, Paul P Just, Wilhelm Devos, Rita Baes, Myriam J Neuroinflammation Research BACKGROUND: Mice with peroxisome deficiency in neural cells (Nestin-Pex5(−/−)) develop a neurodegenerative phenotype leading to motor and cognitive disabilities and early death. Major pathologies at the end stage of disease include severe demyelination, axonal degeneration and neuroinflammation. We now investigated the onset and progression of these pathological processes, and their potential interrelationship. In addition, the putative role of oxidative stress, the impact of plasmalogen depletion on the neurodegenerative phenotype, and the consequences of peroxisome elimination in the postnatal period were studied. METHODS: Immunohistochemistry in association with gene expression analysis was performed on Nestin-Pex5(−/−) mice to document demyelination, axonal damage and neuroinflammation. Also Gnpat(−/−) mice, with selective plasmalogen deficiency and CMV-Tx-Pex5(−/−) mice, with tamoxifen induced generalized loss of peroxisomes were analysed. RESULTS: Activation of the innate immune system is a very early event in the pathological process in Nestin-Pex5(−/−) mice which evolves in chronic neuroinflammation. The complement factor C1q, one of the earliest up regulated transcripts, was expressed on neurons and oligodendrocytes but not on microglia. Transcripts of other pro- and anti-inflammatory genes and markers of phagocytotic activity were already significantly induced before detecting pathologies with immunofluorescent staining. Demyelination, macrophage activity and axonal loss co-occurred throughout the brain. As in patients with mild peroxisome biogenesis disorders who develop regressive changes, demyelination in cerebellum and brain stem preceded major myelin loss in corpus callosum of both Nestin-Pex5(−/−) and CMV-Tx-Pex5(−/−) mice. These lesions were not accompanied by generalized oxidative stress throughout the brain. Although Gnpat(−/−) mice displayed dysmyelination and Purkinje cell axon damage in cerebellum, confirming previous observations, no signs of inflammation or demyelination aggravating with age were observed. CONCLUSIONS: Peroxisome inactivity triggers a fast neuroinflammatory reaction, which is not solely due to the depletion of plasmalogens. In association with myelin abnormalities this causes axon damage and loss. BioMed Central 2012-03-29 /pmc/articles/PMC3419640/ /pubmed/22458306 http://dx.doi.org/10.1186/1742-2094-9-61 Text en Copyright ©2012 Bottelbergs et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the gveative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Bottelbergs, Astrid Verheijden, Simon Van Veldhoven, Paul P Just, Wilhelm Devos, Rita Baes, Myriam Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system |
title | Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system |
title_full | Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system |
title_fullStr | Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system |
title_full_unstemmed | Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system |
title_short | Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system |
title_sort | peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419640/ https://www.ncbi.nlm.nih.gov/pubmed/22458306 http://dx.doi.org/10.1186/1742-2094-9-61 |
work_keys_str_mv | AT bottelbergsastrid peroxisomedeficiencybutnotthedefectinetherlipidsynthesiscausesactivationoftheinnateimmunesystemandaxonallossinthecentralnervoussystem AT verheijdensimon peroxisomedeficiencybutnotthedefectinetherlipidsynthesiscausesactivationoftheinnateimmunesystemandaxonallossinthecentralnervoussystem AT vanveldhovenpaulp peroxisomedeficiencybutnotthedefectinetherlipidsynthesiscausesactivationoftheinnateimmunesystemandaxonallossinthecentralnervoussystem AT justwilhelm peroxisomedeficiencybutnotthedefectinetherlipidsynthesiscausesactivationoftheinnateimmunesystemandaxonallossinthecentralnervoussystem AT devosrita peroxisomedeficiencybutnotthedefectinetherlipidsynthesiscausesactivationoftheinnateimmunesystemandaxonallossinthecentralnervoussystem AT baesmyriam peroxisomedeficiencybutnotthedefectinetherlipidsynthesiscausesactivationoftheinnateimmunesystemandaxonallossinthecentralnervoussystem |